Cronos Group Stock News

DUBLIN, Dec. 7, 2021 /PRNewswire/ -- The "The Pharmaceutical Cannabis Report: 2nd Edition" report has been added to ResearchAndMarkets.com''s offering. The author estimates the market size for the three most widely used cannabinoid pharmaceuticals (Epidiolex , Sativex , dronabinol) to be…

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers ofCronos Group, Inc. ("Cronos" or the "Company") (NASDAQ:CRON). Investors who purchased Cronos sharesare encouraged to obtain additional information and assist the investigation by visiting the firm''s site: www.bgandg.com/cron. The investigation concerns whether Cronos and certain of its officers and/or directors have violated federal securities laws. On November 9, 2021, Cronos filed a Form 8-K with the U.S. Securities and Exchange Commission, stating that "[o]n November 8, 2021, Cronos Group Inc. . . . determined that it will be required ..

A brief overview of our plans for $TONIC, the governance token for Tectonic, and details on how it will be distributed to the Cronos Continue reading on Tectonic »

Zacks Investment Research upgraded shares of Cronos Group (NASDAQ:CRON) from a hold rating to a buy rating in a research report sent to investors on Friday morning, Zacks.com reports. The firm currently has $5.00 target price on the stock. According to Zacks, Cronos Group, Inc. engages in the investment in firms which are licensed to []

Zacks Investment Research lowered shares of Cronos Group from a buy rating to a hold rating in a research note published on Tuesday, Zacks.com reports. According to Zacks

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (Cronos Group or the Company) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders ( NP 12-203 ).

TORONTO, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“ NP 12-203 ”).

Cryptocean (CURRENCY:CRON) traded up 0.6% against the dollar during the one day period ending at 19:00 PM Eastern on December 2nd. One Cryptocean coin can now be purchased for about $2.16 or 0.00003824 BTC on major exchanges. During the last seven days, Cryptocean has traded 2.9% lower against the dollar. Cryptocean has a total market […]

Canada''s main stock index came off a seven-week low Thursday, supported by defensive sectors and financials as major lenders boosted their dividends. The S&P/TSX Composite spiked 297.43 points, or 1.5%, by close of business Thursday to 20,762.03. The Canadian dollar gained 0.0 1 cents at 78.07 cents U.S. Consumer discretionary stocks gained with Magna International better by $4.39, or 4.6% to $100.86, and Martinrea International, taking on 49 cents, or 4.8%, to $10.75. In consumer staples, SunOpta hiked 30 cents, or 4%, to $7.83, and George Weston sprinted $5.26, or 3.9%, to $138.66. Health-care stocks also flourished, with Cronos Group up 24 cents, or 4.4%, to $5.64, and Canopy Growth improving 51 cents, or 4%, to $13.25. Only gold faltered, with Alamos Gold leaning lower 18 cents, or 1.9$, to $9.36, while Iamgold doffed 11 cents, or 2.9%, to $3.72. ON BAYSTREET The TSX Venture Exchange lost 7.7 points to end Thursday at 910.22. All but one of 12 TSX subgroups were in the green, led by consumer discretionary stocks, ahead 2.9%, consumer staples, improving 2.7%, and health-care, up 2.5%.

Top Cannabis Stocks For Current Market Volatility Are you looking for a different way to invest in top marijuana stocks right now? This weeks increased volatility caused by the Omicron variant could be a good opportunity for active traders. As the cannabis sector continues to trade near its lowest value in 2021 the continued delays in the Senate to end cannabis prohibition is threatening to last into next year. This could continue to affect how pot stocks recover from these declines. Some of the most volatile cannabis stocks to watch are marijuana penny stocks. For those not familiar with penny stocks these are any stocks that trade under $5 in the market. Considered a high-risk area of the market these stocks have seen the most gains in 2021 and the steepest declines. Some of the most active cannabis penny stocks have been those attached to Canadian LPs. In general, leading Canadian cannabis companies have much to gain from entry into the US market. This could be why they have seen the most volatile price swings with the delays in federal cannabis reform.

Are Penny Stocks The Best Short Term Investments Right Now? The post Marijuana Penny Stocks To Buy In December? 2 To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News.

Cronos Group (NASDAQ:CRON) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. According to Zacks, Cronos Group, Inc. engages in the investment in firms which are licensed to produce and sell medical marijuana. Its portfolio includes In The Zone, Peace Naturals, Whistler []

Companies covered in cannabis beverages Market are Aurora Cannabis Inc. (Edmonton, Canada), Aphria Inc. (Leamington, Canada), Canopy Growth Corporation (Canada), MedReleaf Corp. (Edmonton, Canada), Cronos Group Inc. (Toronto, Canada), GW Pharmaceuticals, plc. (Cambridge, U.K.), CannTrust Holdings Inc. (Vaughan, Canada), VIVO Cannabis Inc. (Ontario, Canada), Tilray (Nanaimo, Canada), OrganiGram Holdings (Moncton, Canada) and more players profiled Companies covered in cannabis beverages Market are Aurora Cannabis Inc. (Edmonton, Canada), Aphria Inc. (Leamington, Canada), Canopy Growth Corporation (Canada), MedReleaf Corp. (Edmonton, Canada), Cronos Group Inc. (Toronto, Canada), GW Pharmaceuticals, plc. (Cambridge, U.K.), CannTrust Holdings Inc. (Vaughan, Canada), VIVO Cannabis Inc. (Ontario, Canada), Tilray (Nanaimo, Canada), OrganiGram Holdings (Moncton, Canada) and more players profiled

Cronos Group Inc (CRON) shares closed today at 1.8% above its 52 week low of $4.38, giving the company a market cap of $1B. The stock is currently down 35.7% year-to-date, down 47.3% over the past 12 months, and down 41.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 0.6%. Trading Activity Trading volume this week was 61.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Equities research analysts expect that Cronos Group Inc. (NASDAQ:CRON) will announce $18.43 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for Cronos Groups earnings, with the lowest sales estimate coming in at $16.10 million and the highest estimate coming in at $20.00 million. Cronos Group reported []